Supplemental material
Journal of Medical Economics
Volume 27, 2024 - Issue 1
Open access
425
Views
0
CrossRef citations to date
0
Altmetric
Oncology
Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma
Justin Gatwooda College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USACorrespondence[email protected]
View further author information
, View further author information
Anthony Masaquelb Genentech, Inc, South San Francisco, CA, USAView further author information
, David Foxb Genentech, Inc, South San Francisco, CA, USAhttps://orcid.org/0000-0002-5465-1648View further author information
, Daniel Sheinsonb Genentech, Inc, South San Francisco, CA, USAView further author information
, Cameron Jamesb Genentech, Inc, South San Francisco, CA, USAView further author information
, Jia Lib Genentech, Inc, South San Francisco, CA, USAView further author information
, Farah Hossainb Genentech, Inc, South San Francisco, CA, USAView further author information
& Ryan Rossc Genesis Research LLC, Hoboken, NJ, USAView further author information
show all
Pages 738-745
|
Received 05 Dec 2023, Accepted 26 Apr 2024, Published online: 06 May 2024
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.